Unexpectedly large CV benefit with icosapent ethyl in statin-treated patients at high CV risk
AHA 2018 - Chicago, IL, USA3' education - Nov. 20, 2018 - Prof. Erik Stroes, MD
This video was recorded at the congress of the American Heart Association on November 10, 2018, in Chicago, IL, USA.
Prof. Erik Stroes, MD - Amsterdam UMC, loc. AMC, Amsterdam, The Netherlands
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.